PDF] Polo-like kinase 1: target and regulator of anaphase-promoting complex/cyclosome-dependent proteolysis. | Semantic Scholar
Inhibition of polo-like kinase 1 (PLK1) facilitates reactivation of gamma-herpesviruses and their elimination | PLOS Pathogens
Polo-like kinase inhibitors in hematologic malignancies - ScienceDirect
Pharmaceuticals | Free Full-Text | Inhibition of Polo-like Kinase 1 by HMN-214 Blocks Cell Cycle Progression and Inhibits Neuroblastoma Growth
Role of polo-like kinase 1 (PLK1) overexpression in cancer. In addition... | Download Scientific Diagram
Polo-Like Kinase 1 Inhibits the Activity of Positive Transcription Elongation Factor of RNA Pol II b (P-TEFb) | PLOS ONE
Polo-like kinases: conservation and divergence in their functions and regulation | Nature Reviews Molecular Cell Biology
Development of Bifunctional Inhibitors of Polo‐Like Kinase 1 with Low‐Nanomolar Activities Against the Polo‐Box Domain - Scharow - 2016 - ChemBioChem - Wiley Online Library
Functions of Polo-Like Kinases: A Journey From Yeast To Humans | Bentham Science
Switching Polo-like kinase-1 on and off in time and space: Trends in Biochemical Sciences
Polo Like Kinase-enzyme
Cancers | Free Full-Text | The Emerging Role of Polo-Like Kinase 1 in Epithelial-Mesenchymal Transition and Tumor Metastasis
Polo-like Kinase 1 Inhibitors in Human Cancer Therapy: Development and Therapeutic Potential | Journal of Medicinal Chemistry
Cancers | Free Full-Text | The CINs of Polo-Like Kinase 1 in Cancer
Polo-like Kinase 1 Licenses CENP-A Deposition at Centromeres - ScienceDirect
Polo-like kinases: structural variations lead to multiple functions | Nature Reviews Molecular Cell Biology
Autoinhibition and relief mechanism for Polo-like kinase 4 – The Quan Lab
Structural basis for the inhibition of Polo-like kinase 1 | Nature Structural & Molecular Biology
Discovery and development of the Polo-like kinase inhibitor volasertib in cancer therapy | Leukemia